F3Logic’s AbbVie ABBV Stock Holding History

F3Logic’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$336K	Buy	2,076 +153	+8%	+$23.5K	0.07%	131
2022 Q3	$258K	Sell	1,923 -371	-16%	-$53.2K	0.05%	148
2022 Q2	$351K	Sell	2,294 -6,551	-74%	-$1M	0.06%	136
2022 Q1	$1.43M	Sell	8,845 -16,283	-65%	-$2.37M	0.21%	60
2021 Q4	$3.39M	Buy	25,128 +347	+1%	+$41K	0.4%	47
2021 Q3	$2.69M	Buy	24,781 +538	+2%	+$61.5K	0.35%	62
2021 Q2	$2.73M	Buy	24,243 +3,195	+15%	+$360K	0.33%	59
2021 Q1	$2.32M	Sell	21,048 -1,263	-6%	-$135K	0.33%	50
2020 Q4	$2.43M	Sell	22,311 -3,209	-13%	-$308K	0.34%	57
2020 Q3	$2.24K	Sell	25,520 -1,502	-6%	-$141K	0.06%	215
2020 Q2	$2.65M	Buy	27,022 +2,002	+8%	+$176K	0.49%	32
2020 Q1	$1.9M	Buy	+25,020	New	+$2.13M	0.41%	38
2019 Q2	–	Sell	-2,757	Closed	-$218K	–	209
2019 Q1	$218K	Sell	2,757 -23,528	-90%	-$1.92M	0.05%	191
2018 Q4	$2.43M	Buy	+26,285	New	+$2.31M	0.72%	31

Other funds holding ABBV

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

F3Logic's ABBV Position: Q4 2022 in Review

F3Logic increased its AbbVie (ABBV) stake by 8% in Q4 2022, buying an estimated $23.5K and bringing the position to 2,076 shares worth $336K. The position accounts for 0.07% of the portfolio, ranked #131.

F3Logic first reported a position in ABBV in Q4 2018 and has held it in 14 quarters since. The position peaked at $3.39M in Q4 2021. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

F3Logic held 2,076 shares of AbbVie worth $336K as of Q4 2022.
F3Logic bought 153 AbbVie shares in Q4 2022, an estimated $23.5K.
AbbVie made up 0.07% of F3Logic's portfolio in Q4 2022, its #131 holding.
F3Logic first reported a position in AbbVie in Q4 2018 and has held it in 14 quarters since.
F3Logic's AbbVie position peaked at $3.39M in Q4 2021.
3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on F3Logic's 13F filing for Q4 2022, filed 14 Feb 2023.